Mucous Membrane Pemphigoid: A Frustrating Disabling Disease in A 15-year-old Male
Abstract
Mucous membrane pemphigoid (MMP) is a rare chronic autoimmune subepithelial blistering disease characterized by erosive lesions of mucous membranes and skin that typically results in scarring of at least some sites of involvement. A progressive disorder that may result in serious complications including blindness, loss of the airway, and esophageal stricture formation. Most patient experience reduced quality of life specifically with ocular symblepharon and laryngeal destruction. Case: We present a case of a 15-year-old male patient with 1 month-history of multiple tense bullae, difficulty to open the eyes, and hoarseness due to scar lesion in mucous membrane. The patient was reported to have Dermatology Life Quality Index (DLQI) of 15 which implied he had severe disability and decreased quality of life due to his illness. Patient also had symblepharone release operation done by ophthalmologist. A laryngeal reconstruction plan was also carried out by ENT doctor, but the patient couldn’t continue the treatment because of economic problem. Scarring of MMP is a significant complication in many cases. Mucous membrane pemphigoid could cause a lot of disability to the patient and decreased quality of life. Symblepharone release operation was done and laryngeal reconstruction plan was also carried out. Surgical intervention may not curable; however, it may be necessary for restoring function and improving quality of life.
References
Ajith Kumar, L. B. (2020). Direct Immunofluorescence study of Immunobullous Disorders (Doctoral dissertation, Madras Medical College, Chennai).
Al Ramil, A. M., Lamfoon, S., & Mawardi, H. (2023). Dental implants for patients with oral mucosal diseases: A narrative review and clinical guidance. Dental and Medical Problems, 60(4), 687-696. https://doi.org/10.17219/dmp/142871
Hofmann, S. C., Günther, C., Böckle, B. C., Didona, D., Ehrchen, J., Gaskins, M., ... & Schmidt, E. (2022). S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20(11), 1530-1550. https://doi.org/10.1111/ddg.14905
Hofmann, S. C., Günther, C., Böckle, B. C., Didona, D., Ehrchen, J., Gaskins, M., ... & Schmidt, E. (2022). S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20(11), 1530-1550. https://doi.org/10.1111/ddg.14905
Kumari, P., Debta, P., & Dixit, A. (2022). Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer. Frontiers in pharmacology, 13, 825266.
Kutlubay, Z., Keçici, A. S., Çelik, U., & Mat, M. C. (2021). A survey of bullous diseases in a Turkish university hospital: clinicoepidemiologicalcharacteristics and follow-up. Turkish Journal of Medical Sciences, 51(1), 124-133. https://doi.org/10.3906/sag-2006-231
Leal-Silva, T., de Almeida Lopes, C., Vieira-Santos, F., Oliveira, F. M. S., Kraemer, L., Padrão, L. D. L. S., ... & Bueno, L. L. (2022). Tissue eosinophilia correlates with mice susceptibility, granuloma formation and damage during Toxocara canis infection. Parasitology, 149(7), 893-904. https://doi.org/10.1017/S0031182022000075
Mei, K. L., & Peters, S. M. (2021). Mucous Membrane Pemphigoid: Report of a Case and Literature Review. New York State Dental Journal, 87(4), 33-37.
Miyamoto, D., Gordilho, J. O., Santi, C. G., & Porro, A. M. (2022). Epidermolysis bullosa acquisita. Anais Brasileiros de Dermatologia, 97, 409-423.
Mohanapriya, L. (2020). Clinical and Immunohistopathological study of Dermatological Lesions in a Tertiary Care Centre (Doctoral dissertation, Madras Medical College, Chennai).
Mulder, P. P., Vlig, M., Boekema, B. K., Stoop, M. M., Pijpe, A., Van Zuijlen, P. P., ... & Ulrich, M. M. (2021). Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles. Frontiers in Immunology, 11, 621222. https://doi.org/10.1016/j.bone.2024.117029
Ormond, M., McParland, H., Thakrar, P., Donaldson, A. N. A., Andiappan, M., Cook, R. J., ... & Setterfield, J. F. (2020). Validation of an Oral Disease Severity Score (ODSS) tool for use in oral mucous membrane pemphigoid. British Journal of Dermatology, 183(1), 78-85.
Rashid, H., Lamberts, A., Borradori, L., Alberti‐Violetti, S., Barry, R. J., Caproni, M., ... & Horváth, B. (2021). European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part I. Journal of the European Academy of Dermatology and Venereology, 35(9), 1750-1764. https://doi.org/10.1111/jdv.17397
Siriwardena, B. S. M. S., & Jayasinghe, R. (2023). A Patient Presenting with Desquamative Gingivitis: Mucous MembranePemphigoid. In Clinicopathological Correlation of Oral Diseases (pp. 541-550). Cham: Springer International Publishing.
Copyright (c) 2024 Journal La Medihealtico

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.